Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

CEO Jim Buck Says Mardil Medical is Using Familiar Script to Rewrite the Rules on Treating FMR

March 28, 2018

Jim Buck, President and CEO of Mardil Medical, shares his personal and professional Medtech stories. The common thread? He doesn’t give up. One result may be Mardil pushing for the rebirth of a once high-flying Medtech technology. In this podcast you’ll hear:

His tragic, but uplifting path to Medtech.
Where his first stint as CEO went wrong.
How he came to Mardil.
How he believes Mardil will succeed where others haven’t

Jim Buck

President & CEO

Mardil Medical

Jim Buck joined Mardil Medical in September, 2010 after more than nineteen years of experience successfully developing and commercializing innovative medical technologies. Prior to joining Mardil, Jim served as President & CEO of SetPoint Medical, VP, marketing & business development at InnerPulse, and VP, marketing & business development at Closure Medical (through acquisition by Johnson & Johnson).  Previous to Closure Medical/J&J, Jim held several positions of increasingly greater responsibility over eleven years at cardiac medical device leader St. Jude Medical. Jim holds a master of management from Northwestern University’s Kellogg Graduate School of Management and a bachelor’s degree in marketing from Indiana University. STAY UP TO DATE WITH HEALTHEGY! Get the latest news, podcasts and videos. Subscribe Today! SUBSCRIBE TODAY